TrialJournal of global oncology2019

Randomized, Double-Blind, Pharmacokinetic Equivalence Trial Comparing DRL-Rituximab With MabThera in Patients With Diffuse Large B-Cell Lymphoma.

Auro Viswabandya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.